Calhoun Vision Light Adjustable Lens (LAL) in Subjects With Pre-Existing Corneal Astigmatism
NCT ID: NCT01496066
Last Updated: 2018-06-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
600 participants
INTERVENTIONAL
2011-12-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of the Calhoun Vision Light Adjustable Intraocular Lens (LAL)
NCT00845520
A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
NCT04005586
Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
NCT03660865
Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism
NCT03729024
Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism
NCT03771352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LAL
LAL implanted
LAL (Light Adjustable Lens) and Light Deliver Device (LDD)
LAL implanted and adjusted with LDD
Monofocal control
Monofocal control IOL implanted
Monofocal control IOL
Commercially available monofocal intraocular lens (IOL)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LAL (Light Adjustable Lens) and Light Deliver Device (LDD)
LAL implanted and adjusted with LDD
Monofocal control IOL
Commercially available monofocal intraocular lens (IOL)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pre-operative regular corneal astigmatism of \>= 0.75 diopters and \<= 2.0 diopters
* Best spectacle corrected visual acuity reduced to 20/40 or worse with or without glare
* Projected best spectacle corrected visual acuity of 20/20 or better
* Clear intraocular media other than cataract
* Potentially good vision in fellow eye
* Fully dilated pupil of \>= 7.0 mm
Exclusion Criteria
* Pseudoexfoliation
* Age related macular degeneration
* Retinal degenerative disorder
* Diabetes with any evidence of retinopathy
* Glaucomatous optic neuropathy, uveitis, significant anterior segment pathology, keratoconus
* Corneal dystrophy, previous corneal or intraocular surgery
* Complications during cataract surgery
* Serious co-morbid conditions
* Systemic medications that my increase UV sensitivity
* Irregular astigmatism
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Calhoun Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vold Vision
Fayetteville, Arkansas, United States
Jules Stein Eye Institute
Los Angeles, California, United States
Wolstan & Goldberg Eye Associates
Torrance, California, United States
Newsom Eye
Sebring, Florida, United States
Arbor Centers for Eye Care
Orland Park, Illinois, United States
Eye Surgeons of Indiana
Indianapolis, Indiana, United States
Jones Eye Clinic
Sioux City, Iowa, United States
Discover Vision & Laser Center
Leawood, Kansas, United States
Minnesota Eye Consultants, PA
Bloomington, Minnesota, United States
Ophthalmology Consultants, Ltd.
St Louis, Missouri, United States
EyeSight Ophthalmic Services, PA
Somersworth, New Hampshire, United States
Carolina Vision Center
Fayetteville, North Carolina, United States
Cleveland Eye Clinic
Brecksville, Ohio, United States
Vance Thompson Vision
Sioux Falls, South Dakota, United States
Eye Consultants of Texas
Grapevine, Texas, United States
Focal Point Vision
San Antonio, Texas, United States
Hoopes Vision
Draper, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSP-002-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.